Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.14%3.36B | 9.33%2.92B | -6.14%2.6B | 7.09%10.91B | 0.25%2.73B | 1.45%2.75B | 7.88%2.67B | 21.08%2.76B | 18.44%10.19B | 11.78%2.72B |
| Cost of revenue | 14.47%2.42B | 3.13%2.05B | -3.78%1.95B | 9.65%8.36B | 12.01%2.24B | 5.06%2.11B | 6.42%1.99B | 15.67%2.03B | 15.42%7.63B | 8.36%2B |
| Gross profit | 47.48%941.83M | 27.38%869.44M | -12.62%645.65M | -0.53%2.55B | -32.24%490.15M | -8.89%638.61M | 12.36%682.57M | 38.89%738.91M | 28.44%2.56B | 22.48%723.32M |
| Operating expense | 425.09%461.64M | 33.80%317.16M | 1.62%263.44M | 40.70%584.2M | 214.87%632.94M | -157.06%-142.01M | 364.31%237.04M | -4.45%259.25M | -23.90%415.2M | 336.81%201.01M |
| Selling and administrative expenses | ---- | ---- | ---- | 0.07%1.06B | ---- | ---- | ---- | ---- | 18.13%1.06B | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -41.26%137.1M | ---- | ---- | ---- | ---- | 80.79%233.4M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 11.69%926.8M | ---- | ---- | ---- | ---- | 7.64%829.8M | ---- |
| Other operating expenses | -3.70%556.01M | 41.07%508.92M | -3.99%362.89M | ---- | 61.19%734.11M | 55.49%577.38M | 2.82%360.77M | 2.30%377.97M | ---- | --455.42M |
| Total other operating income | -86.88%94.37M | 54.99%191.77M | -16.23%99.45M | -25.97%479.7M | -60.23%101.17M | 487.54%719.38M | -58.73%123.73M | 20.97%118.72M | 82.84%648M | 229.81%254.4M |
| Operating profit | -38.49%480.19M | 23.96%552.28M | -20.32%382.21M | -8.50%1.97B | -127.34%-142.79M | 72.69%780.62M | -19.93%445.53M | 84.00%479.66M | 48.13%2.15B | -22.67%522.3M |
| Net non-operating interest income (expenses) | -9.35%-219.91M | -9.56%-196.04M | -25.87%-184.2M | -8.77%-691M | -0.79%-164.59M | -22.08%-201.1M | -12.68%-178.93M | 1.40%-146.35M | -6.47%-635.3M | -8.45%-163.31M |
| Non-operating interest expense | -13.00%174.95M | -10.87%159.48M | 4.00%152.21M | 4.05%623.8M | -2.44%159.33M | 22.08%201.1M | 12.68%178.93M | -1.40%146.35M | 14.65%599.5M | 112.69%163.31M |
| Total other finance cost | -29.70%44.96M | -0.57%36.56M | 62.02%32M | 87.71%67.2M | --5.26M | --63.95M | --36.77M | --19.75M | -51.49%35.8M | ---- |
| Net investment income | 163.52%113.2M | 31.72%-178.2M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -257.50%-6.3M | 200.00%4M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -83.33%2.5M | 338.10%15M | ||||||||
| Income from associates and other participating interests | 97.72%-730K | 34.99%-42.28M | 9.43%-67.56M | -5.64%-232.4M | -26.95%-60.76M | -2.62%-32.04M | 11.36%-65.03M | -10.49%-74.6M | -43.51%-220M | 13.66%-47.86M |
| Special income (charges) | 76.90%-2.7M | 0 | 0 | -5.41%-35.1M | 0 | 8.39%-11.68M | -10,459.33%-22.07M | 61.55%-1.33M | 91.92%-33.3M | 94.25%-16.89M |
| Less:Write off | -76.90%2.7M | --0 | --0 | 5.41%35.1M | --0 | -8.39%11.68M | 10,459.33%22.07M | -61.55%1.33M | -91.92%33.3M | -94.25%16.89M |
| Other non-operating income (expenses) | 701.38%189.35M | 137.82%53.5M | -47.73%-630.2M | 110.33%23.63M | -141.45M | -18.80%-426.6M | ||||
| Income before tax | -52.06%256.86M | 147.77%503.31M | 58.67%183.94M | -27.81%486.7M | -225.12%-368.14M | 120.19%535.79M | 113.00%203.14M | 180.78%115.93M | 297.02%674.2M | 179.01%294.24M |
| Income tax | 1,372.71%159.24M | -25.09%105.19M | 66.61%132.03M | 3.61%324.6M | 53.29%117.41M | -114.72%-12.51M | 115.73%140.43M | -8.60%79.24M | -3.66%313.3M | -20.69%76.59M |
| Net income | -82.20%97.62M | 534.90%398.12M | 41.50%51.92M | -55.08%162.1M | -323.09%-485.55M | 246.27%548.31M | 107.13%62.71M | 180.80%36.69M | 154.08%360.9M | 146.41%217.65M |
| Net income continuous operations | -82.20%97.62M | 534.90%398.12M | 41.50%51.92M | -55.08%162.1M | -323.09%-485.55M | 246.27%548.31M | 107.13%62.71M | 180.80%36.69M | 154.08%360.9M | 146.41%217.65M |
| Noncontrolling interests | -5.84%-22.07M | 4.64%-18.62M | 2.05%-20.66M | -17.39%-89.1M | -25.72%-27.65M | -9.42%-20.86M | -15.91%-19.53M | -16.99%-21.09M | 48.51%-75.9M | 70.68%-21.99M |
| Net income attributable to the company | -78.97%119.69M | 406.76%416.75M | 25.60%72.58M | -42.49%251.2M | -291.08%-457.9M | 220.83%569.16M | 74.52%82.24M | 311.05%57.78M | 184.00%436.8M | 160.82%239.64M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -78.97%119.69M | 406.76%416.75M | 25.60%72.58M | -42.49%251.2M | -291.08%-457.9M | 220.83%569.16M | 74.52%82.24M | 311.05%57.78M | 184.00%436.8M | 160.82%239.64M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -78.98%0.0211 | 406.90%0.0735 | 25.49%0.0128 | -42.54%0.0443 | -291.02%-0.0808 | 220.77%0.1004 | 74.70%0.0145 | 312.50%0.0102 | 183.99%0.0771 | 160.86%0.0423 |
| Diluted earnings per share | -78.98%0.0211 | 406.90%0.0735 | 25.49%0.0128 | -42.54%0.0443 | -291.02%-0.0808 | 220.77%0.1004 | 74.70%0.0145 | 312.50%0.0102 | 183.99%0.0771 | 160.86%0.0423 |
| Dividend per share | 0 | 0 | -55.56%0.04 | 0.00%0.15 | 0 | 0.00%0.06 | 0 | 0.00%0.09 | 150.00%0.15 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.